Lifevantage Corporation
Recent
price
P/E
ratio
div
yld
3.13%
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- LifeVantage Corporation (Nasdaq: LFVN), founded in 2003 and headquartered in Lehi, Utah, engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators and related health and wellness products through a direct sales model with independent distributors. The company offers a portfolio of scientifically validated products including the flagship Protandim family (Nrf2 Synergizer and NRF1 Synergizer) for reducing oxidative stress and enhancing cellular energy; TrueScience anti-aging skin and hair care products such as liquid collagen, facial cleansers, eye creams, moisturizers, hand creams, shampoos, conditioners, and scalp serums; the MindBody GLP-1 System and PhysIQ weight management system featuring supplements, meal replacements, and lifestyle guidance; AXIO nootropic energy drink mixes; Petandim pet supplements for dogs; activation-supporting nutrients like Omega and D3+; and the Rise AM & Reset PM System. It operates in the Americas (United States, Canada, Mexico), Asia/Pacific (Japan, Hong Kong, Australia, Thailand, Philippines, Taiwan, Singapore, New Zealand), and Europe (United Kingdom, Netherlands, Germany, Austria, Spain, Ireland, Belgium). In September 2025, LifeVantage announced the acquisition of LoveBiome's key operating assets, a direct sales company focused on microbiome health solutions including the P84 product, expected to close by mid-October 2025, enhance revenue growth, and be accretive to adjusted EPS and EBITDA in the first year while expanding its consultant network and gut health offerings.
Company News
New Strong Sell Stocks for October 19th
LifeVantage Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
LifeVantage Unveils Turnaround Plan to Rebuild Brand, Margins and Growth
LifeVantage to Participate in the WTR Virtual Insights Conference on Wednesday, September 23, 2026
LifeVantage Corporation (LFVN) Q4 2026 Earnings Call Transcript
Lifevantage Q4 Earnings Call Highlights
LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2026
LifeVantage Declares Quarterly Dividend
LifeVantage to Announce Fourth Quarter and Full Fiscal Year 2026 Results on August 27, 2026
LifeVantage Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
LifeVantage Welcomes Terrence Moorehead as Chief Executive Officer
Do Options Traders Know Something About LifeVantage Stock We Don't?
LifeVantage Corporation (LFVN) Q3 2026 Earnings Call Transcript
Lifevantage (LFVN) Q3 Earnings and Revenues Miss Estimates
LifeVantage Declares Quarterly Dividend
LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2026
Strength Seen in Lifevantage (LFVN): Can Its 8.5% Jump Turn into More Strength?
Lifevantage (NASDAQ:LFVN) Share Price Crosses Below 200-Day Moving Average – What’s Next?
LifeVantage to Announce Third Quarter Fiscal Year 2026 Results on May 6, 2026
LifeVantage Receives U.S. Patent for Healthy Glow Essentials Stack